ArticleJournal of neurology2022

Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod.

Rocco Capuano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.